Humana’s board of directors declared a $0.885 per share dividend to be paid April 24.
The dividend will be paid to all shareholders of record as of the close of business March 27, according to a Feb. 19 Humana news release.
Humana recorded a net loss of $796 million in the fourth quarter of 2025, according to the company’s year-end earnings report published Feb. 11. The results reflect a higher medical loss ratio driven by a shift in business mix and the impact of the Inflation Reduction Act on the company’s prescription drug plans.
In 2025, the company’s net income totaled nearly $1.2 billion, down 1.6%. Humana is projecting earnings per share of at least $8.89 for 2026, with an adjusted EPS of at least $9.00.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
